APVO
Aptevo Therapeutics·NASDAQ
--
--(--)
--
--(--)
APVO fundamentals
Aptevo Therapeutics (APVO) released its earnings on Aug 11, 2025: revenue was 0 (YoY --), met estimates; EPS was -151.2 (YoY +99.32%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-151.2
+99.32%
Report date
Aug 11, 2025
EPS
Actual | -1793404.8 | -1230768 | -1260072 | -1060804.8 | -1019779.2 | -1043222.4 | -849816 | -761904 | -931867.2 | 3252942.095 | -898116.611 | -621244.8 | 152380.8 | -720878.4 | -293040 | -178887.6 | -132534 | -22244.4 | -6393.6 | -3218.4 | -1580.4 | -151.2 | ||||||
Forecast | -820512 | -1240536 | -1201464 | -908424 | -980707.2 | -1172160 | -838094.4 | -758973.6 | -673992 | -779486.4 | -955310.4 | -896702.4 | -694504.8 | -656409.6 | -375091.2 | -263736 | -143456.4 | -25707.6 | -7592.4 | -2790 | -1515.6 | -1497.6 | ||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -118.57% | +0.79% | -4.88% | -16.77% | -3.98% | +11.00% | -1.40% | -0.39% | -38.26% | +517.32% | +5.99% | +30.72% | +121.94% | -9.82% | +21.88% | +32.17% | +7.61% | +13.47% | +15.79% | -15.35% | -4.28% | +89.90% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | 0 | 473.00K | 1.50M | 2.37M | 2.42M | 3.11M | 3.10M | 3.66M | 3.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- | 0 |
Forecast | -- | -- | -- | -- | -- | -- | 4.50M | 290.00K | 563.67K | 2.22M | 2.42M | 1.35M | 3.10M | 3.40M | 3.75M | 3.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | +63.10% | +166.11% | +7.08% | 0.00% | +130.37% | 0.00% | +7.71% | -16.96% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
No Data
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
